chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had contacted his healthcare provider the day following his vaccination stating that his left arm was numb from the shoulder down to his hand and he was in a lot of pain. He states it started a few hours after the vaccination. They instructed him to go to walk in care, but patient said he is not able due to the pain in his arm and has no way for someone to get him there as he lives in an assisted living/senior center. They were going to call him back and advise him to call 911 if symptoms got worse, etc. We called the patient a few times in the days following the incident, each time he stated it is slowly getting better, although still somewhat stiff and slightly painful.
Patient is experiencing, itchiness and rash over entire body which commenced on the evening after administration of immunization. Pt states putting lotion to soothe itchiness but refused any other treatment.
This spontaneous report as received from a physician via a company representative, refers to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL dose 2. Batch number, lot number and expiry date were not reported. Patient had received first two doses of the GARDASIL vaccination series. No concomitant medications were reported. On an unknown date the patient was diagnosed with papillary thyroid cancer (medically significant). The outcome of papillary thyroid cancer was reported as not recovered. The causality of the event to suspect product was unknown. Upon internal review the event of papillary thyroid cancer was considered medically significant. Additional information has been requested.
pt says the day after taking the vax she said she could feel the injection going through her body.  She started waking up during the night feeling like someone was choking her because he throat and esophagus swelling.  She said she felt like her stomach was irritated and began having acid reflux.  She had an episode of feeling very dizzy on her left side of her head.  On 4/27/21 she had another episode of getting very dizzy and started vomiting.  Today she says her head is not hurting but does not feel normal.  She says her the left ear and left eye is hurting a little and she cannot sleep on that side of her body.  Pt will call her PCP regarding her symptoms.    .
Patient complained of feeling dizzy 5 minutes after vaccination. Patient was tachypneic, slightly tachytardic, and was hypertensive. Patient remained warm, pink, and dry. Patient was concious, breathing, and alert through time of transfer of care upon EMS arrival. Paramedic evaluated, no signs of an allergic reaction, vitals taken, assisted EMS with cardiac monitoring which showed patient in a sinus rhythm without ectopy. Patient remained stable through trasnfer to EMS. EMS transported.
Presented at ER with screaming, fussy, fever 101.5. IMP fussiness suspected vaccine RX.
This spontaneous report was received from a female patient of unknown age regarding herself. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX, (lot number, expiry date was unknown). On an unknown date, the patient experienced itchy eyes and has itching sensation of her neck and face. The outcome of the events were unknown. Additional information is not expected.
Shortly post second dose of vax, pt experienced 'super migraines, disturbed sleep, and auditory hallucinations.' The pt sought unspecified medical attention. No further information is available.
Reported not feeling well and had aches in shoulders and neck. Discomfort increased 7/28/17 drove self to ER that afternoon because of severe swelling in the neck and throat, unable to talk be 5:00pm. ER gave injection, thinks maybe steroid which helped her breathing and talking. Remained in ER until 12:00 am for observation and then released home.
I started having pains on my side, all the way down to my legs.  I had chills, fever, I went to the doctor. They did chest x-rays, urine tests, blood tests, stomach x-rays, COVID-19 test. We found that I was positive for COVID-19, found I have some blood in my urine. I was treated for both COVID-19 with the Paxlovid and an antibiotic for the blood in my urine. I am feeling great.
Received first injection on 1-8-2921, Sore and a quarter size red area appeared with itching, Second injection on  2-8-2921.  Soreness and itching continued. I applied cortizona ointment and took bendryl inn hopes it would disappear. After weeks of area continuing to grow now about 4 X 6 inches , severe itching, reddness and sore arm with some pin pricking sensations, I decided to see my  physician at facility I received injections.  I was prescribed methylpred tab 4mg, a prednisone med for 5 days. Today I took my first tablet in the morning. I can however let you know if the treatment helped after I am finished with meds.
Severe arm pain lasting over 2 weeks. Pain is worsening rather than improving. I have tried ibuprofen and Tylenol
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Visual Changes/Disturbances-Mild
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 23-JUN-2014 the patient was vaccinated with a dose of ZOSTAVAX, 0.65 ml, subcutaneous (lot# not reported) that had expired on 07-JUN-2014. No adverse effect was reported. Additional information has been requested.
Fever chills aches. Heart rate went into tachycardia with a heart rate up to 200BPM. Rush to the ER by ambulance. Treated and sent home with a heart rate of 95-100BPM
took first dose on3/2/21 on right arm took second dose on 3/23/21 on left arm on 5/1/21 stated on burning shooting pain on left whole arm, persisting till now, gabapentin not helping
Given Adult dose of Hep B Vaccine (1.0ml) instead of child dose (0.5ml);  Not negative symptoms post injection.
4-8 hours after the vaccine shot, headache, chills, muscle weakness, exhaustion - redness and itching increased as redness area has progressively increased and tissue area (redness) feels dense. Returned to the clinic the next morning and (another PA) examined and said the effects are "normal" but have gotten worse since.
Pt had injection on 5/24/18 - she stated that after receiving the injection, her arm near site of injection started weeping and eventually dried into a crusty and scaly area. Today is now 7/3/18 and she stated she still has a bumpy patch near site of injection. She did not receive medical treatment for this.
Patient complained of significant pain in L arm resulting in visit to ER and urgent care hours at PCP office on same date 10/19/19. Very slight edema was noted but no erythema, no signs of infection, no fevers. Patient reported pain with any movement of arm
reported feeling lightheaded after vaccine. she reports feeling this way frequently after getting vaccines. placed in supine position. symptoms resolved upon discharge.
This initial spontaneous report as received from a lawyer regarding a case in litigation refers to a female patient of unknown age. The patient's medical history, concurrent conditions, and concomitant medications were not provided. On or about 28-SEP-2011, the patient was vaccinated with ZOSTAVAX (dose, route, and lot number not provided) at a pharmacy as recommended for routine adult health maintenance and for the long-term prevention of shingles. The vaccine did not prevent shingles as intended and, on an unspecified date, the patient contracted a persistent strain of herpes zoster. On or about 09-AUG-2016, the patient was treated at a medical center for a persistent and severe vesicular rash which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain, suffering, and other damages. The outcome of vaccination failure and herpes zoster was unknown. The reporter considered vaccination failure and herpes zoster to be related to ZOSTAVAX. Additional information has been requested.
Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     It was unknown if patient had received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Patient received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    Concomitant medication list was not provided. It was reported that 196 patients received 0.25mL of Moderna COVID-19 vaccine, Bivalent. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live follow up: updated patient demographic details.
A few hours after the vaccine I started feeling fatigued and having chills.  I was so tired and sleepy I slept almost all day for the first 48 hrs after. Developed fever between 100.5-101 which lasted about 18hrs which did require me to have to call into work the following day.  2/3 I developed swelling and pain in the lymph nodes under my right arm and breast.  The swelling subsided within 4days but I still have some tenderness to date.  I took tylenol and ibuprophen for the first 48 hours to help with all the symptoms.
Patient hasn't received 2nd dose past 36 days; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient hasn't received 2nd dose past 36 days) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient hasn't received 2nd dose past 36 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient hasn't received 2nd dose past 36 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Diarrhea, would not eat/drink, & spitting up, fever 100, excessive crying 7PM-12AM; MD did not prescribe any tx stated it would wear off;
Information has been received from a registered nurse for the Pregnancy Registry for GARDASIL, concerning a 17 year old female with depressive disorder and no known drug allergies who on 17-AUG-2007 and 11-MAY-2009 was vaccinated with first dose (lot number 656051/0244U) and second dose (659184/0843X), respectively of GARDASIL. Concomitant therapy included LEXAPRO. On an unspecified date after the patient received the second dose of GARDASIL, a PAP test was positive for HPV. The registered nurse reported that the patient is now pregnant. The patient's LMP was on 01-JUN-2009 and the EDT was 08-MAR-2010. The registered nurse reported that there was an abnormality in fetus. An initial ultrasound by their office found an abnormality and the patient was referred to an unspecified perinatologist who did another ultrasound which also showed the abnormality. There were additional work ups being done followed by perinatologist and by their office. Follow up information was received from a Licensed Practical Nurse. She reported the patient was being seen for her Ob/Gyn care. The patient received 2 doses of GARDASIL at her Pediatrician's office: the first dose was administered on 17-AUG-2007 (Lot number 656051/0244U, route not reported) and the second dose was given on 11-MAY-2009 (Lot # 659184/0843X). The patient has a history of Bipolar disorder for which she was being treated with LEXAPRO (start date not reported). The patient's LMP was reported as 01-JUN-2009 and her EDD is 08-MAR-2010. The licensed practical nurse further added that the maternal great uncle of the baby's father had a history of mental retardation. The patient was on no other concomitant medications and had no other vaccinations at the same time as her GARDASIL injections. After the patient discovered she was pregnant, she stopped taking LEXAPRO (stop date not reported). The patient had a body rash during her first trimester (no further details were provided). The patient underwent a pregnancy ultrasound, the following was noted: The fetus has a misshapen skull with anterior and posterior bulging at the forehead. The cranial contents could not be assessed due to gestational age. The fetus's left foot is partially present and fine amniotic bands were present in the amniotic fluid. The Impression of this study was of amniotic band syndrome (which was not confirmed). The LPN reported that the physician felt as though the prognosis was grim and fetal defects would be fatal, but was unsure. The patient is scheduled to have a consult with a Perinatologist on 08-OCT-2009. The patient refused an amniocentesis and was planning on continuing with the pregnancy at this time. Skull malformation, congenital deformity of foot, and Amniotic Band Syndrome were considered congenital anomalies. Additional information has been requested.
Following day pt. presented with redness and swelling on bicep of arm injected. No pain. Saw ER MD and was prescribed antibiotic. (Clindamycin 300 mg 1 q 6 h x 5 d).
Patient states that after receiving BEXSERO vaccine her left arm was painful and she has difficulty moving it.
Extreme itching especially in the left arm where the vaccine was administered.  Itching of the eyes and face and tingling itching feeling of the scalp as well.  Took antihistamine to relieve itching and symptoms reduced in intensity somewhat but did not go away.  Small raised bumps but not full blown hives on bath arms, face and chest.
Vertigo, dizziness, nausea.  It comes stronger in waves, but I have no appetite and baseline dizziness.  I am having trouble walking straight and I bump into things or trip over them.  I have fallen because I was not steady.  If I get up too fast everything gets dark and it feels like I'm going to pass out.  I'm also experiencing brain fog: it's hard to think and I'm really forgetful.  It also seemed to trigger a manic episode, like the first vaccine did.  I can't sleep my normal amount.  My initial effects, for the first 48 hours, were the typical pain, headache, and intense fatigue.  Those are mostly better, aside from fatigue and mild headache.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021 at 10:51 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 11-Jan-2021 at 10:51 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 26.25.  Concomitant products were not provided.  On 11-Jan-2021, Excursion time was 2 P, temperature was 35, total doses given for the day was 98, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 8-Jan-2021, vial was moved to clinic on 11-Jan-2021. 9 vials were sent to clinic. Vaccine BUD date was 2-Feb-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
A mother reported that her 14 month old son received his first dose of Rota Shield in April, 1999 and subsequently developed a fever of 100 F. The infant recovered.
Fever, chills, body aches, severe pain at injection side, weakness, headache.
This spontaneous report as received from a pharmacy technician concerning a currently 2 years old child. Gender was not reported. Medical history and concurrent conditions were not reported. On 27-MAR-2014, the patient was vaccinated with VARIVAX (Merck) lot #J007955; expiration date 27-JUN-2015, (doe, strength and route were not reported). Secondary and concomitant therapies were not reported. Patient was vaccinated with VARIVAX (Merck) that was exposed to 43.1 degrees F for 29 hours on 03-MAR-2014. This is one of several reports from the same reporter. Additional information has been requested.
Headache, chills, fever, sore shoulder with pain going up into my neck and lower jaw, and swelling on left side of neck, lightheaded, and shaky.
This spontaneous report as received from a consumer concerning herself of unknown age and gender with allergies to surfactant in PNEUMOVAX23, who on an unspecified date was vaccinated with PNEUMOVAX23 (dose and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The consumer reported that while in PNEUMOVAX23, developed a huge knot at the vaccination site (date unspecified). No treatment information was reported. The patient sought medical attention. On an unspecified date, the patient recovered from adverse event after stopping therapy. PNEUMOVAX23 was discontinued and not reintroduced. The relatedness for the adverse event was unknown for the PNEUMOVAX23. Additional information has been requested.
HIVES 2 HOURS POST VACCINE NEEDED PO BENADRYL AND IM BENADRYL
I got hives within a few hours.  Rash type right arm few inches below injection site  Also rash under both breasts, What looked like insect bites. larger than mosquito about 8 over body and upper legs and itchy. Also I have gotten muscle pain in right leg. and still do.
Itchy at injection site; Pink at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE ERYTHEMA (Pink at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy at injection site) and VACCINATION SITE ERYTHEMA (Pink at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (Itchy at injection site) was resolving and VACCINATION SITE ERYTHEMA (Pink at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product were not provided.
PNEUMOVAX 23 administered 9/28/10, on 9/29/10 area very red. Pt low grade fever. Pt's doctor Dx cellulitis.
sprain; swelling; fell; Some pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 25 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "chronic migraines" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for Covid-19 Immunization. The following information was reported: LIGAMENT SPRAIN (non-serious) with onset 2021, outcome "unknown", described as "sprain"; SWELLING (non-serious) with onset 2021, outcome "unknown", described as "swelling"; FALL (non-serious) with onset 2021, outcome "unknown", described as "fell"; ARTHRALGIA (non-serious) with onset 2021, outcome "unknown", described as "Some pain".  Additional information: As patient was a sports person got Sprain while working on sports got injury and happened after vaccination. Unsure timeline but believe large space between the two, during the follow up patient experienced swelling initially so they could not tell if it was fracture. They've said it has hurt more than usual in the past couple of days. They are currently in a brace; they will be in a boot for four more weeks for their foot to fully heal. They were given also the option of a hard shoe (cannot remember if can immediately do that or not), reporter mentioned about the potential ligament issue but nothing further, and no new information was updated during the follow-up's.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Headache, NauseaVomiting, fatigue and headache with nausea Narrative:
"Vaccine at clinic around 8am. Started feeling warm and nauseated 2 hrs after. Home and went to shower at 12:30, sweating, dizzy and nauseated. Bent to wash feet and felt like passing out. Grabbed soap dish and pulled it off the wall, fell on left knee, got up and went to bed. Dizziness passed. Stayed home next day with sore throat." Did not report this until several days later. Employee Health investigated that at clinic patient was very anxious and worked up about getting flu shot. He did not want medical treatment. Never had flu shot before, was very nervous and hesitant to receive it.
He lost consciousness after the second vaccine (FLUVIRIN) I gave in the right Deltoid. For about 5 seconds while sitting in the chair. I felt his body tightening and falling forward. He did not fall but was going to slump over. Called 911 and vitals were taken. His vitals were ok and they left. He got a ride from his girlfriend.